Heart, Vascular & Thoracic Institute (Miller Family) Outcomes
Preventive Cardiovascular
LDL Levels Among Statin-Intolerant Adults
Primary and Secondary Prevention
Primary Cardiovascular Disease Prevention: Statin-Intolerant Adults
2023, N = 346
Patients referred to the Preventive Cardiology department for primary prevention who could not tolerate statins experienced reductions in low-density lipoprotein (LDL) levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.
LDL = low-density lipoprotein
Source: EPIC
Secondary Cardiovascular Disease Prevention: Statin-Intolerant Adults
2023, N = 492
Patients referred to the Preventive Cardiology department for secondary prevention who could not tolerate statins experienced reductions in low-density lipoprotein (LDL) levels. Patients were seen at baseline, defined as their first visit, and had at least 2 follow-up visits within the past 2 years. The time between visits varied from patient to patient.
LDL = low-density lipoprotein
Source: EPIC